Merck

Company ● Covered in 3 stories + Follow ✴ AI Graph

This profile is built automatically from TLDRocket coverage.

Signals

2 stories (+100%)

Media momentum

As of 4 Sep 2026 · Visible stories in the last 30 days, compared with the 30 days before.

3 sources

Source diversity

As of 4 Sep 2026 · Distinct publications behind this entity's visible coverage.

—

Release activity

As of 4 Sep 2026 · Model, product and open-source release events in the last 90 days whose coverage involves this entity.

—

Funding signals

As of 4 Sep 2026 · Funding and acquisition events in the last 90 days whose coverage involves this entity.

Jul 2026 → Aug 2026

Coverage span

As of 4 Sep 2026 · First to most recent month of TLDRocket coverage of this entity.

updated 5 Aug 2026

Robert M. Davis President & CEO
Sanat Chattopadhyay EVP & President, Merck Manufacturing Division
Beth Perrone Senior Vice President, Chief Talent & Strategy Officer
Fran Geatens Chief Technology Officer & Senior Vice President
Brian Foard Executive vice president and president, Specialty, Pharma & Infectious Diseases
Richard R. DeLuca Jr. EVP & President, Merck Animal Health
Jennifer Zachary EVP, General Counsel & Corporate Secretary
Gregg Szabo Senior Vice President, Merck, And President, Global Vaccines & Infectious Diseases
Ellen Lambert Exec VP Merck Company Foundation
Chirfi Guindo Executive Vice President, Strategic Access, Policy & Communications; Member of the Executive Team
Richard DeLuca Executive Vice President and President Animal Health
Jannie Oosthuizen President Global Oncology & MSD International